La vendita allo scoperto per Pyxus International dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Pyxus International. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Pyxus International (OTC:PYYX) Azioni, Report sulle vendite allo scoperto

Pyxus International Inc is a world-wide agricultural company delivering value-added products and services to businesses, customers, and consumers. The company and its subsidiaries and affiliates are providers of responsibly sourced, independently verified, sustainable and traceable agricultural and consumer-driven products and ingredients. The company's products are categorized under leaf, legal cannabis, industrial hemp and CBD, and e-liquids. Its segment comprises Leaf and Other. The company has a presence in North America, South America, Europe, Asia, and Africa.

PYXUS INTL INC NEW by Pyxus International, Inc.

Pyxus International Inc

Macro Economic Events

WIIM

Economics

SPDR Dow Jones Industrial Average ETF Trust

Major indexes are higher after April PPI figures came in softer than expected.

<ul>
<li>N of 1 therapy uniquely developed, on demand, for infant with life-threatening rare metabolic disorder in six months</li>
<li>Results published in The New England Journal of Medicine and showcased at American Society of Gene &amp; Cell Therapy Annual Meeting</li>
</ul>
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.aldevron.com&amp;esheet=54255056&amp;newsitemid=20250514568719&amp;lan=en-US&amp;anchor=Aldevron&amp;index=1&amp;md5=f817bb3d6d74ace1490fe4a80bca7115">Aldevron</a>, a global leader in the production of DNA, RNA and protein, together with <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.idtdna.com&amp;esheet=54255056&amp;newsitemid=20250514568719&amp;lan=en-US&amp;anchor=Integrated+DNA+Technologies&amp;index=2&amp;md5=3ebfea33eaf0cf1493d0e4f15900af7e">Integrated DNA Technologies</a> (IDT), a global leader in genomics solutions, announced the successful manufacture of the world's first personalized CRISPR gene editing drug product to treat an infant with urea cycle disorder (UCD). With no current cure for UCDs, the Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania (Penn) engaged Aldevron and IDT, both part of <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.danaher.com&amp;esheet=54255056&amp;newsitemid=20250514568719&amp;lan=en-US&amp;anchor=Danaher+Corporation&amp;index=3&amp;md5=16d1e6e69c20a6d0ce98005bd100f544">Danaher Corporation</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) to manufacture a novel mRNA-based personalized CRISPR therapy in six months—three times faster than the standard timeline for gene editing drug products.

News

Aldevron And Integrated DNA Technologies Manufacture World's First mRNA-Based Personalized CRISPR Gene Editing Drug Product To Treat Infant With Urea Cycle Disorder

IDAI

Trust Stamp shares are trading higher after the company announced a strategic partnership with Partisia.

Analyst Ratings

Trading Ideas

ADBE

KNSL

KNTK

MSFT

CNBC Halftime Report Final Trades: Adobe, Microsoft, Kinetik Holdings, Kinsale Capital Group

ATRA

Atara Biotherapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.

In a heated national debate over the future of Social Security, former Acting Social Security Administration Commissioner <a href="https://www.benzinga.com/personal-finance/25/04/45029508/ssa-acting-commissioner-says-wasteful-dei-and-gender-ideology-contributed-to-poor-customer-servi">Leland Dudek</a> has pushed back against what he calls "media hysteria," claiming that President Donald Trump is improving — not gutting — the vital program.&nbsp;
But critics, including former President Joe Biden and Democratic lawmakers, argue the opposite. So, who's right?
<h2 class="wp-block-heading">Trump-Era Changes: &#8216;Bold, Not Bureaucratic&#8217;</h2>
In a recent New York Post <a href="https://nypost.com/2025/05/06/opinion/dont-trust-social-security-hysteria-trump-delivers-results/">opinion piece</a>, Dudek credited the Trump administration with transforming the SSA's operations. "We are delivering real results," he wrote, citing efforts to modernize the agency and deliver benefits more efficiently. According to Dudek, over $14.8 billion in delayed retroactive payments were made to 2.2 million Americans in the first 100 days of the administration.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
</ul>
He also pointed to cost-saving efforts — more than $1 billion through reductions in travel, contracts, and other administrative expenses — as well as new AI-powered customer service tools and wage reporting improvements expected to save $3 billion over the next decade.
"We are rebuilding trust, not through headlines or hashtags, but through hard work and honest service," Dudek said.
<h2 class="wp-block-heading">Critics Warn of Staffing Cuts and Disruptions</h2>
But many aren&#8217;t convinced that these reforms are purely beneficial. <a href="https://www.benzinga.com/government/25/04/44941777/social-security-payments-could-face-interruptions-in-may-warns-former-commissioner-martin-omalley-never-hoped-i-was-wrong-so-much-in-my-life">Martin O'Malley</a>, SSA commissioner during the Biden administration, has expressed concern that staffing reductions and operational changes could disrupt benefits delivery. In an <a href="https://www.democracynow.org/2025/4/28/martin_omalley_social_security">interview</a> with Democracy Now, O'Malley warned that cutbacks could "cascade into a collapse of the entire system."
Biden echoed these concerns in an April speech at the Advocates, Counselors and Representatives for the Disabled conference in Chicago, accusing the Trump administration of taking a "hatchet" to Social Security. "They've slashed the agency's operations," Biden said, calling the changes "breathtaking" and "devastating."
He cited the 7,000 employees the SSA has vowed to push out in just a few months, including experienced staff vital to the system's stability. Biden also referenced delays, SSA website crashes, and cases of recipients being incorrectly declared deceased.
Trending: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a>
<h2 class="wp-block-heading">Legal Challenges Add More Scrutiny</h2>
Beyond political pushback, the Trump administration's reforms have also faced legal scrutiny. A <a href="https://www.benzinga.com/25/03/44438870/extremely-worrisome-and-surprising-federal-judge-considers-emergency-order-to-block-doge-from-social-security-systems">federal judge</a> recently issued an injunction preventing the White House's Department of Government Efficiency from accessing sensitive SSA data, including Social Security numbers and medical records. Critics say the rushed rollout of new systems may compromise privacy and oversight.
<h2 class="wp-block-heading">A Clash of Visions for Social Security</h2>
Supporters of the Trump-era reforms argue that modernizing the SSA is essential after years of slow service and red tape. Dudek claimed that field offices have remained open and that technology upgrades are helping to cut long wait times.
Opponents argue the pace and scope of the changes risk undermining the very program they aim to improve. Biden warned of further cuts tied to making the 2017 Trump tax cuts permanent, calling out billionaires who've referred to Social Security as a "Ponzi scheme."
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
<h2 class="wp-block-heading">What It Means for Americans</h2>
At the heart of the debate is a fundamental question: Can <a href="https://www.benzinga.com/personal-finance/25/05/45335763/you-could-still-lose-half-your-benefits-social-security-reduces-overpayment-withholding-rate-experts-warn-of-fallout">Social Security</a> be modernized without weakening it?
While Dudek insists the agency is becoming faster, leaner, and more accountable, critics caution that essential services — and the people who rely on them — could be left behind.
As reforms continue, seniors and their families should keep a close eye on how these changes affect service delivery and benefit access in the months ahead.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Previous Acting SSA Commissioner Slams Media 'Hysteria,' Says Trump Is Saving Social Security — Is He Right?

GCT Semiconductor Holding, Inc. ("GCT" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCTS#NYSE">GCTS</a>), a leading designer and supplier of advanced 5G and 4G semiconductor solutions, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 7,006,370 shares of its common stock and warrants to purchase up to 10,509,555 shares of common stock at a combined purchase price of $1.57 per share and accompanying warrant in a registered direct offering priced at the market under NYSE rules.
The warrants will have an exercise price of $1.71 per share, will become exercisable six months from issuance and will expire five years following such initial date of exercise. The offering is expected to close on or about May 16, 2025, subject to the satisfaction of customary closing conditions.
The gross proceeds from the offering are expected to be approximately $11 million, before deducting placement agent fees and other offering expenses payable by the Company. GCT intends to use the net proceeds from the offering for working capital and other general corporate purposes.

GCTS

GCT Semiconductor Prices Direct Offering At $1.57/Shr, Selling 7M Shares & 10.5M Warrants

Johnson Controls Intl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) short percent of float has fallen 6.67% since its last report. The company recently reported that it has 9.83 million shares sold short, which is 1.96% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.58 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Johnson Controls Intl Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747328447_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Johnson Controls Intl has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Johnson Controls Intl's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Johnson Controls Intl's peer group average for short interest as a percentage of float is 5.05%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Is Johnson Controls Intl Gaining or Losing Market Support?

In the current market session, United Airlines Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) stock price is at $77.36, after a 2.07% drop. However, over the past month, the company's stock went up by 16.68%, and in the past year, by 40.72%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1747328447_0_0.png" alt="Past Year Chart" />

<h3>Evaluating United Airlines Holdings P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
United Airlines Holdings has a lower P/E than the aggregate P/E of 14.65 of the Passenger Airlines industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1747328447_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

P/E Ratio Insights for United Airlines Holdings

BlackRock's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) short percent of float has fallen 12.5% since its last report. The company recently reported that it has 1.70 million shares sold short, which is 1.12% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.58 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>BlackRock Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747328442_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for BlackRock has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing BlackRock's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, BlackRock's peer group average for short interest as a percentage of float is 4.05%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into BlackRock's Recent Short Interest

Nutanix's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NYSE">NTNX</a>) short percent of float has risen 8.16% since its last report. The company recently reported that it has 6.99 million shares sold short, which is 3.05% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.47 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Nutanix Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747328436_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Nutanix has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Nutanix's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Nutanix's peer group average for short interest as a percentage of float is 3.02%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

NTNX

Is Nutanix Gaining or Losing Market Support?

BZAI

Blaize Holdings shares are trading lower after the company reported worse-than-expected Q1 EPS results.

EDAP

Edap TMS shares are trading lower after the company reported Q1 financial results and missed its EPS and revenue estimates.

VRAR

Glimpse Group shares are trading higher following Q3 financial results.

MRSN

Mersana Therapeutics shares are trading lower after the company reported worse-than-expected Q1 sales results.

FOSL

Fossil Group shares are trading higher after the company reported a year-over-year increase in Q1 adjusted EPS results.

CABA

Cabaletta Bio shares are trading higher after the company announced its eyeing a 2027 BLA submission for rese-cel in myositis after aliging with the FDA on registrations cohorts.

Needham analyst Tom Nikic downgrades Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) from Buy to Hold and announces $24 price target.

Downgrades

Price Target

Needham Downgrades Foot Locker to Hold, Announces $24 Price Target

IXHL

Incannex Healthcare shares are trading highera fter the company reported a year-over-year increase in Q3 EPS results.

UOKA

MDJM shares are trading lower after the company announced a 25-for-1 share consolidation.

Small Cap

Press Releases

Pyxus International Appoints New Chief Legal Officer and Secretary

Pyxus International, Inc. Retires $20 Million of Senior Secured Notes at Maturity

Commodities

Pyxus International, Inc. Announces Second Quarter Fiscal Year 2025 Financial Results Earnings Call

/C O R R E C T I O N -- Pyxus International, Inc./

Earnings

Pyxus International, Inc. Reports Strong Second Quarter Fiscal 2025 Results

Pyxus Releases Fiscal Year 2024 Sustainability Report

Pyxus International, Inc. Announces Third Quarter Fiscal Year 2025 Financial Results Earnings Call

Comments

Pyxus International

Vendite allo scoperto

Pyxus International (OTC:PYYX) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO